KLRS Kalaris Therapeutics, Inc.
Nasdaq · SEC CIK 1754068 · EDGAR
- Bought, last 12 months
- $6.18M 2 purchases by 2 insiders
- Sold, last 12 months
- $12.9K 1 sales by 1 insiders
- Filings on record
- 250 since 2021-09-20, latest 2026-08-28 16:10
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Samsara Opportunity Fund, L.P. | 10% | $5.00M | — |
| AKKARAJU SRINIVAS | Dir, 10% | $1.18M | — |
| Hagen Brett R | CAO | — | $12.9K |
Transactions 221
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-10-23 | 2023-10-19+ | KLRS | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $1.56 | -2,707 | 1.17M | -0.2% | -$4,218 |
| M | 2023-10-23 | 2023-10-19+ | KLRS | Hagen Brett R | CAO | S - Sale | $1.56 | -715 | 126.6K | -0.6% | -$1,115 |
| 2023-10-23 | 2023-10-19 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $1.58 | -8,581 | 882.0K | -1.0% | -$13.6K | |
| 2023-10-05 | 2023-10-03 | KLRS | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $1.98 | -755 | 1.17M | -0.1% | -$1,495 | |
| 2023-10-05 | 2023-10-03 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $1.98 | -1,325 | 890.6K | -0.1% | -$2,624 | |
| 2023-10-05 | 2023-10-03 | KLRS | Hagen Brett R | CAO | S - Sale | $1.98 | -222 | 127.0K | -0.2% | -$439.56 | |
| M | 2023-08-21 | 2023-08-17+ | KLRS | Brainard Diana | CEO, Dir | S - Sale | $2.58 | -15.4K | 895.9K | -2% | -$39.7K |
| 2023-08-21 | 2023-08-17 | KLRS | Hagen Brett R | CAO | S - Sale | $2.50 | -1,653 | 127.2K | -1% | -$4,132 | |
| 2023-08-21 | 2023-08-17 | KLRS | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $2.50 | -10.5K | 1.17M | -0.9% | -$26.3K | |
| M | 2023-07-21 | 2023-07-19+ | KLRS | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $3.45 | -2,635 | 1.19M | -0.2% | -$9,079 |
| M | 2023-07-21 | 2023-07-19+ | KLRS | Hagen Brett R | CAO | S - Sale | $3.46 | -684 | 129.2K | -0.5% | -$2,363 |
| 2023-07-21 | 2023-07-19 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $3.56 | -8,342 | 907.3K | -0.9% | -$29.7K | |
| 2023-07-06 | 2023-07-05 | KLRS | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $3.05 | -2,983 | 1.19M | -0.3% | -$9,098 | |
| 2023-07-06 | 2023-07-05 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $3.05 | -5,275 | 915.6K | -0.6% | -$16.1K | |
| D | 2023-07-05 | 2023-07-03 | KLRS | Piccina Cintia | Chief Commercial Off | A - Grant | $0.00 | +147.0K | 147.0K | New | $0 |
| 2023-06-28 | 2023-06-27 | KLRS | GILEAD SCIENCES, INC. | 10% | P - Purchase | $3.75 | +2.93M | 16.64M | +21% | +$10.99M | |
| 2023-06-13 | 2023-06-09 | KLRS | Hagen Brett R | CAO | S - Sale | $5.64 | -5,045 | 129.5K | -4% | -$28.5K | |
| 2023-05-19 | 2023-05-18 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $4.21 | -4,536 | 916.6K | -0.5% | -$19.1K | |
| 2023-05-12 | 2023-05-11 | KLRS | Bornstein Jeffrey S | Dir | A - Grant | $0.00 | +35.0K | 75.2K | +87% | $0 | |
| 2023-05-12 | 2023-05-11 | KLRS | Adams Derek N. | Dir | A - Grant | $0.00 | +35.0K | 35.0K | New | $0 | |
| 2023-05-12 | 2023-05-11 | KLRS | Jovan-Embiricos Morana | Dir, 10% | A - Grant | $0.00 | +35.0K | 65.2K | +116% | $0 | |
| 2023-05-12 | 2023-05-11 | KLRS | Tomasello Shawn | Dir | A - Grant | $0.00 | +35.0K | 35.0K | New | $0 | |
| 2023-05-12 | 2023-05-11 | KLRS | Vera Juan | Dir | A - Grant | $0.00 | +35.0K | 2.37M | +1% | $0 | |
| 2023-05-12 | 2023-05-11 | KLRS | Brenner Malcolm | Dir | A - Grant | $0.00 | +35.0K | 65.2K | +116% | $0 | |
| 2023-05-12 | 2023-05-11 | KLRS | Hallal David | Dir, 10% | A - Grant | $0.00 | +35.0K | 2.11M | +2% | $0 | |
| 2023-04-21 | 2023-04-19 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $3.71 | -8,408 | 921.2K | -0.9% | -$31.2K | |
| M | 2023-04-21 | 2023-04-19+ | KLRS | Hagen Brett R | CAO | S - Sale | $3.67 | -697 | 134.6K | -0.5% | -$2,558 |
| M | 2023-04-21 | 2023-04-19+ | KLRS | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $3.67 | -2,683 | 1.19M | -0.2% | -$9,837 |
| 2023-02-23 | 2023-02-21 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $6.63 | -5,122 | 929.6K | -0.5% | -$34.0K | |
| DM | 2023-02-03 | 2022-01-18+ | KLRS | Leen Ann M. | CSO | A - Grant | $0.00 | +81.0K | 65.3K | New | $0 |
| D | 2023-02-03 | 2023-02-02 | KLRS | Sinha Vikas | See Remarks, Dir, 10% | A - Grant | $0.00 | +157.5K | 1.19M | +15% | $0 |
| D | 2023-02-03 | 2023-02-02 | KLRS | Hagen Brett R | CAO | A - Grant | $0.00 | +61.2K | 135.3K | +83% | $0 |
| D | 2023-02-03 | 2023-02-02 | KLRS | Miller Edward | GC | A - Grant | $0.00 | +87.5K | 236.0K | +59% | $0 |
| D | 2023-02-03 | 2023-02-02 | KLRS | Brainard Diana | CEO, Dir | A - Grant | $0.00 | +332.5K | 935.0K | +55% | $0 |
| 2023-01-23 | 2023-01-19 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $5.08 | -34.4K | 601.6K | -5% | -$174.9K | |
| M | 2023-01-23 | 2023-01-19+ | KLRS | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $5.09 | -6,537 | 1.03M | -0.6% | -$33.3K |
| M | 2023-01-23 | 2023-01-19+ | KLRS | Hagen Brett R | CAO | S - Sale | $5.09 | -1,895 | 74.3K | -2% | -$9,647 |
| I | 2023-01-23 | 2022-12-02 | KLRS | Miller Edward | GC | G - Gift | $0.00 | +98.3K | 288.8K | +52% | $0 |
| 2023-01-23 | 2022-12-02 | KLRS | Miller Edward | GC | G - Gift | $0.00 | -98.3K | 151.0K | -39% | $0 | |
| M | 2023-01-23 | 2023-01-19+ | KLRS | Miller Edward | GC | S - Sale | $5.09 | -2,573 | 148.5K | -2% | -$13.1K |
| 2022-11-21 | 2022-11-18 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $7.27 | -4,515 | 633.0K | -0.7% | -$32.8K | |
| 2022-11-18 | 2022-11-16 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $7.50 | -16.1K | 333.7K | -5% | -$120.6K | |
| I | 2022-11-16 | 2022-11-14 | KLRS | Miller Edward | GC | S - Sale | $8.91 | -2,358 | 190.5K | -1% | -$21.0K |
| 2022-11-15 | 2022-11-11 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $8.20 | -36.6K | 349.8K | -9% | -$300.1K | |
| M | 2022-11-14 | 2022-11-10+ | KLRS | Hagen Brett R | CAO | S - Sale | $8.14 | -24.0K | 75.9K | -24% | -$195.2K |
| M | 2022-11-10 | 2022-11-08+ | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $8.00 | -13.4K | 399.5K | -3% | -$107.3K |
| A | 2022-10-26 | 2022-10-20 | KLRS | Hagen Brett R | CAO | S - Sale | $9.36 | -345 | 113.2K | -0.3% | -$3,229 |
| MA | 2022-10-26 | 2022-10-20+ | KLRS | Atillasoy Ercem | See Remarks | S - Sale | $8.72 | -2,095 | 132.9K | -2% | -$18.3K |
| A | 2022-10-26 | 2022-10-20 | KLRS | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $9.36 | -1,449 | 1.04M | -0.1% | -$13.6K |
| A | 2022-10-26 | 2022-10-20 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $9.36 | -1,070 | 399.8K | -0.3% | -$10.0K |
| A | 2022-10-26 | 2022-10-20 | KLRS | Miller Edward | GC | S - Sale | $9.36 | -553 | 249.4K | -0.2% | -$5,176 |
| M | 2022-10-24 | 2022-10-19+ | KLRS | Atillasoy Ercem | See Remarks | S - Sale | $8.72 | -2,095 | 132.9K | -2% | -$18.3K |
| 2022-10-24 | 2022-10-19 | KLRS | Sinha Vikas | See Remarks, Dir, 10% | S - Sale | $9.36 | -1,449 | 1.04M | -0.1% | -$13.6K | |
| M | 2022-10-24 | 2022-10-19+ | KLRS | Hagen Brett R | CAO | S - Sale | $8.43 | -13.7K | 101.9K | -12% | -$115.3K |
| 2022-10-24 | 2022-10-19 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $9.36 | -1,070 | 399.8K | -0.3% | -$10.0K | |
| 2022-10-24 | 2022-10-19 | KLRS | Miller Edward | GC | S - Sale | $9.36 | -553 | 249.4K | -0.2% | -$5,176 | |
| I | 2022-10-21 | 2022-10-19 | KLRS | Hallal David | Dir, 10% | S - Sale | $8.45 | -600.0K | 138.2K | -81% | -$5.07M |
| I | 2022-09-30 | 2022-09-29 | KLRS | Hallal David | Dir, 10% | S - Sale | $7.35 | -400.0K | 721.0K | -36% | -$2.94M |
| 2022-09-06 | 2022-09-02 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $7.89 | -493 | 400.9K | -0.1% | -$3,890 | |
| 2022-08-19 | 2022-08-18 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $7.76 | -4,564 | 637.5K | -0.7% | -$35.4K | |
| 2022-08-17 | 2022-08-16 | KLRS | Hagen Brett R | CAO | A - Grant | $0.00 | +20.0K | 113.6K | +21% | $0 | |
| 2022-08-17 | 2022-08-16 | KLRS | Leen Ann M. | CSO | A - Grant | $0.00 | +15.0K | 43.0K | +54% | $0 | |
| 2022-08-17 | 2022-08-16 | KLRS | Sinha Vikas | See Remarks, Dir | A - Grant | $0.00 | +100.0K | 1.04M | +11% | $0 | |
| 2022-08-17 | 2022-08-16 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | A - Grant | $0.00 | +15.0K | 401.4K | +4% | $0 | |
| 2022-08-17 | 2022-08-16 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $8.30 | -15.6K | 386.4K | -4% | -$129.4K | |
| 2022-08-17 | 2022-08-16 | KLRS | Miller Edward | GC | A - Grant | $0.00 | +15.0K | 249.9K | +6% | $0 | |
| 2022-08-17 | 2022-08-16 | KLRS | Brainard Diana | CEO, Dir | A - Grant | $0.00 | +100.0K | 642.1K | +18% | $0 | |
| MI | 2022-08-01 | 2022-07-28 | KLRS | Jovan-Embiricos Morana | Dir, 10% | A - Grant | $4.61 | +8.15M | 2.06M | New | +$37.58M |
| I | 2022-08-01 | 2022-07-28 | KLRS | Sinha Vikas | See Remarks, Dir, 10% | A - Grant | $4.61 | +3.25M | 16.67M | +24% | +$15.00M |
| I | 2022-08-01 | 2022-07-28 | KLRS | GADICKE ANSBERT | Dir, 10% | A - Grant | $4.61 | +3.25M | 16.67M | +24% | +$15.00M |
| 2022-08-01 | 2022-07-28 | KLRS | ElevateBio, LLC | Dir, 10% | A - Grant | $4.61 | +3.25M | 16.67M | +24% | +$15.00M | |
| I | 2022-08-01 | 2022-07-28 | KLRS | Hallal David | Dir, 10% | A - Grant | $4.61 | +3.25M | 16.67M | +24% | +$15.00M |
| 2022-07-22 | 2022-07-21 | KLRS | Atillasoy Ercem | See Remarks | S - Sale | $5.38 | -1,533 | 133.5K | -1% | -$8,248 | |
| 2022-07-21 | 2022-07-20 | KLRS | Sinha Vikas | See Remarks, Dir | S - Sale | $5.21 | -1,432 | 938.2K | -0.2% | -$7,461 | |
| 2022-07-21 | 2022-07-20 | KLRS | Atillasoy Ercem | See Remarks | S - Sale | $5.21 | -563 | 135.0K | -0.4% | -$2,933 | |
| 2022-07-21 | 2022-07-20 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $5.21 | -1,058 | 402.0K | -0.3% | -$5,512 | |
| 2022-07-21 | 2022-07-21 | KLRS | Hallal David | Dir, 10% | S - Sale | $5.33 | -4,227 | 2.07M | -0.2% | -$22.5K | |
| D | 2022-07-06 | 2022-07-01 | KLRS | Hagen Brett R | CAO | A - Grant | $0.00 | +10.5K | 93.6K | +13% | $0 |
| D | 2022-07-06 | 2022-07-01 | KLRS | Atillasoy Ercem | See Remarks | A - Grant | $0.00 | +14.0K | 135.6K | +12% | $0 |
| D | 2022-07-06 | 2022-07-01 | KLRS | Miller Edward | GC | A - Grant | $0.00 | +14.0K | 234.9K | +6% | $0 |
| D | 2022-07-06 | 2022-07-01 | KLRS | Sinha Vikas | See Remarks, Dir | A - Grant | $0.00 | +29.4K | 939.7K | +3% | $0 |
| D | 2022-07-06 | 2022-07-01 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | A - Grant | $0.00 | +14.0K | 403.0K | +4% | $0 |
| D | 2022-07-06 | 2022-06-03 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $3.63 | -515 | 389.0K | -0.1% | -$1,869 |
| D | 2022-07-06 | 2022-07-01 | KLRS | Brainard Diana | CEO, Dir | A - Grant | $0.00 | +48.1K | 542.1K | +10% | $0 |
| 2022-06-06 | 2022-06-03 | KLRS | Hallal David | Dir, 10% | S - Sale | $3.67 | -65.7K | 2.08M | -3% | -$241.2K | |
| 2022-05-23 | 2022-05-18 | KLRS | Brainard Diana | CEO, Dir | S - Sale | $4.33 | -29.1K | 492.2K | -6% | -$126.2K | |
| 2022-05-18 | 2022-05-17 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $4.40 | -15.3K | 389.5K | -4% | -$67.2K | |
| 2022-04-28 | 2022-04-26 | KLRS | Bornstein Jeffrey S | Dir | P - Purchase | $4.64 | +5,000 | 40.2K | +14% | +$23.2K | |
| 2022-04-22 | 2022-04-21 | KLRS | Hallal David | Dir, 10% | S - Sale | $5.87 | -4,227 | 2.14M | -0.2% | -$24.8K | |
| 2022-04-22 | 2022-04-20 | KLRS | Sinha Vikas | See Remarks, Dir | S - Sale | $6.68 | -1,162 | 906.6K | -0.1% | -$7,762 | |
| 2022-04-22 | 2022-04-20 | KLRS | Hagen Brett R | CAO | S - Sale | $6.68 | -276 | 80.4K | -0.3% | -$1,844 | |
| M | 2022-04-22 | 2022-04-20+ | KLRS | Atillasoy Ercem | See Remarks | S - Sale | $6.04 | -2,040 | 121.6K | -2% | -$12.3K |
| 2022-04-22 | 2022-04-20 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | S - Sale | $6.68 | -852 | 404.8K | -0.2% | -$5,691 | |
| D | 2022-04-04 | 2022-01-18 | KLRS | Sinha Vikas | See Remarks, Dir | A - Grant | $0.00 | +48.8K | 907.8K | +6% | $0 |
| D | 2022-04-04 | 2022-01-18 | KLRS | Brainard Diana | CEO, Dir | A - Grant | $0.00 | +315.0K | 521.3K | +153% | $0 |
| D | 2022-04-04 | 2022-01-18 | KLRS | Hagen Brett R | CAO | A - Grant | $0.00 | +17.4K | 80.6K | +28% | $0 |
| D | 2022-04-04 | 2022-01-18 | KLRS | VAN BEEK JEROEN B | Chief Commercial Off | A - Grant | $0.00 | +23.3K | 405.6K | +6% | $0 |
| D | 2022-04-04 | 2022-01-18 | KLRS | Miller Edward | GC | A - Grant | $0.00 | +23.3K | 217.3K | +12% | $0 |
| D | 2022-04-04 | 2022-01-18 | KLRS | Atillasoy Ercem | See Remarks | A - Grant | $0.00 | +23.3K | 123.6K | +23% | $0 |
| M | 2022-03-11 | 2022-03-10+ | KLRS | Hallal David | Dir, 10% | S - Sale | $7.48 | -65.7K | 2.15M | -3% | -$491.7K |
Purchase Sale Sale after option exercise All abbreviations